Last $45.91 USD
Change Today +0.63 / 1.39%
Volume 760.9K
ALKS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nancy J. Wysenski B.Sc., MBA

Director and Member of Nominating & Corporate Governance Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 49 board members in 3 different organizations across 8 different industries.

See Board Relationships
56$1,076,917

Background*

Ms. Nancy J. Wysenski, B.Sc., MBA served as the Chief Commercial Officer and Executive Vice President of Vertex Pharmaceuticals Incorporated from December 2009 to June 2012. Ms. Wysenski has broad responsibility for sales, marketing, market research and sales operations activities as the Vertex creates and executes commercial plans to support the potential launch of its late-stage product opportunities. She served as Chief Operating Officer of Endo Pharmaceuticals Solutions ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

Director
2002-2004
Former Director
2004-N/A
Former Director, Chairman of Compensation Committee, Member of Special Finance Committee and Member of Nominating & Corporate Governance Committee
2009-N/A
Former Chief Operating Officer and Director
2011-N/A
Former Director
2013-Present
Director and Member of Nominating & Corporate Governance Committee
2014-Present
Independent Director and Member of Compensation Committee

Education*

BS
Kent State University
MBA
Baldwin-Wallace College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$51,268
Total Calculated Compensation$1,076,917
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALKS:US $45.91 USD +0.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Alessandro E. Della Chà LL.MChief Executive Officer and Director
Cosmo Pharmaceuticals S.p.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.